ALLY BRIDGE GROUP
Ally Bridge Group is a global healthcare-focused investment group committed to venture and growth capital, buyout, and hedge fund investing. Ally Bridge Group was founded by Frank Yu in July 2013 and is based in New York and Hong Kong.
ALLY BRIDGE GROUP
Industry:
Finance Financial Services Venture Capital
Founded:
2013-07-01
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics WordPress Google Universal Analytics Apache Wordpress Plugins
Similar Organizations
CDH Investments
CDH Investments is an international alternative asset fund manager with more than $2.0 billion of committed capital under management.
Global Founders Capital
GFC is a globally oriented, stage agnostic venture fund that empowers gifted entrepreneurs.
Gobi Partners
Gobi Partners is the most interconnected Pan-Asian venture capital firm across North Asia, South Asia, and ASEAN.
Horizons Ventures
Horizons Ventures focuses on investing in disruptive and technology-focused start-ups.
Sequoia Capital China
Sequoia Capital China is a VC firm focused on seed stage, mid stage, late stage, and growth investments in the fintech sector.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-07-27 | Syapse | Ally Bridge Group investment in Venture Round - Syapse | 35 M USD |
| 2022-06-16 | Aerin Medical | Ally Bridge Group investment in Private Equity Round - Aerin Medical | 60 M USD |
| 2022-03-10 | RefleXion Medical | Ally Bridge Group investment in Venture Round - RefleXion Medical | 80 M USD |
| 2022-02-07 | Endeavor BioMedicines | Ally Bridge Group investment in Series B - Endeavor BioMedicines | 101 M USD |
| 2022-01-11 | Transcarent | Ally Bridge Group investment in Series C - Transcarent | 200 M USD |
| 2021-11-09 | Arbor Biotechnologies | Ally Bridge Group investment in Series B - Arbor Biotechnologies | 215 M USD |
| 2021-11-02 | Shoreline Biosciences | Ally Bridge Group investment in Series B - Shoreline Biosciences | 140 M USD |
| 2021-10-19 | Quantum Surgical | Ally Bridge Group investment in Venture Round - Quantum Surgical | 40 M EUR |
| 2021-09-24 | Elligo Health Research | Ally Bridge Group investment in Series E - Elligo Health Research | 135 M USD |
| 2021-08-04 | Sonoma BioTherapeutics | Ally Bridge Group investment in Series B - Sonoma BioTherapeutics | 265 M USD |